Phenothiazines Inhibit Hepatitis C Virus Entry, Likely by Increasing the Fluidity of Cholesterol-Rich Membranes

Despite recent progress in the development of direct-acting antiviral agents against hepatitis C virus (HCV), more effective therapies are still urgently needed. We and others previously identified three phenothiazine compounds as potent HCV entry inhibitors. In this study, we show that phenothiazin...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Chamoun-Emanuelli, Ana M., Pecheur, Eve-Isabelle, Simeon, Rudo L., Huang, Da, Cremer, Paul S., Chen, Zhilei
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Society for Microbiology 2013
Gaiak:
Antiviral Agents
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3716126/
https://ncbi.nlm.nih.gov/pubmed/23529728
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02593-12
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak